Businessweek: Israel’s TEVA is One of The World’s Best Companies 2009

No. 20 Teva Pharmaceutical  2008 Annual Sales (millions): $10,458 Sales CAGR (2004-2008): 20.4% Value CAGR (2004-2008): 8.6%  Based in Israel, Teva is the largest generic pharmaceuticals manufacturer. The company produces generic drugs faster and in greater quantities than its competition, and its also the only generic drugmaker with its own branded drug, Copaxone, for treatment of multiple sclerosis. More than 80% of its sales (over $11 billion in 2008) come from the U.S. and Europe. The generics market worldwide is growing much faster than the prescription business as governments and insurers push for the use of less expensive generics. Pictured above is Teva Chairman Eli Hurvitz.

No. 20 Teva Pharmaceutical 2008 Annual Sales (millions): $10,458 Sales CAGR (2004-2008): 20.4% Value CAGR (2004-2008): 8.6% Based in Israel, Teva is the largest generic pharmaceuticals manufacturer. The company produces generic drugs faster and in greater quantities than its competition, and it's also the only generic drugmaker with its own branded drug, Copaxone, for treatment of multiple sclerosis. More than 80% of its sales (over $11 billion in 2008) come from the U.S. and Europe. The generics market worldwide is growing much faster than the prescription business as governments and insurers push for the use of less expensive generics. Pictured above is Teva Chairman Eli Hurvitz.

Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s